Durataf 25 Tablet 30's
₹1477.8*
MRP ₹1642
10% off
₹1396*
MRP ₹1642
15% CB
₹246 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
DURATAF 25MG TABLET belongs to the group of medicines known as ‘antiviral medicines used to treat chronic hepatitis B virus (HBV) infection in adults with compensated liver disease. Chronic hepatitis B is a long-term viral infection caused by the hepatitis B virus.
DURATAF 25MG TABLET contains ‘Tenofovir alafenamide’. It inhibits HBV replication by incorporating the HBV reverse transcriptase into viral DNA, resulting in DNA chain termination. Thereby, it prevents the virus from producing new viruses and clears the infection.
Take DURATAF 25MG TABLET as prescribed by your doctor. Therapy should be initiated by a physician experienced in managing chronic hepatitis B. You may sometimes experience headaches, diarrhoea, vomiting, feeling sick (nausea), and rash. Most of these side effects of DURATAF 25MG TABLET do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
You should not take DURATAF 25MG TABLET if you are allergic to DURATAF 25MG TABLET or any other contents present in it. Avoid taking DURATAF 25MG TABLET if you have or had a history of severe kidney or liver impairment. Inform your doctor if you are pregnant, planning to become pregnant, and breastfeeding. Avoid drinking alcohol as it may increase the risk of side effects. You are recommended to avoid driving while using DURATAF 25MG TABLET as it may cause dizziness, affecting your ability to drive or use machines. Should not use DURATAF 25MG TABLET for children less than 12 years of age. Patients should take necessary precautions to avoid infecting others.
DURATAF 25MG TABLET ‘tenofovir alafenamide’, an antiviral drug used to treat hepatitis B virus (HBV) infection in adults with compensated liver disease. It inhibits HBV replication by incorporating the HBV reverse transcriptase into viral DNA, resulting in DNA chain termination. Thereby it prevents the virus from producing new viruses and cleans up your infection.
Diarrhoea
Vomiting
Feeling sick (nausea)
Dizziness
Stomach pain
Joint pain
Feeling bloated
Wind (flatulence)
Feeling tired
You should not take DURATAF 25MG TABLET if you are allergic to DURATAF 25MG TABLET or any other contents present in it. Avoid taking DURATAF 25MG TABLET if you have or had a history of severe kidney or liver impairment. Inform your doctor if you are pregnant, planning to become pregnant, and breastfeeding. Avoid drinking alcohol as it may increase the risk of side effects. You should not drive while using DURATAF 25MG TABLET as DURATAF 25MG TABLET may cause dizziness, affecting your ability to drive or use machines. DURATAF 25MG TABLET is not recommended for children less than 12 years of age. Patients should take necessary precautions to avoid infecting others.
Drug-Drug Interactions: DURATAF 25MG TABLET may interact with an antibiotic (e.g. tobramycin, pentamidine, vancomycin), antifungal medicines (e.g. amphotericin B), antiviral disease (e.g. foscarnet, ganciclovir), medications used to treat hepatitis B virus (e.g. adefovir), pain killer (e.g. ibuprofen). The relevance of a particular drug interaction varies from person to person.
Drug-Food Interactions: Avoid drinking alcohol. Consuming alcohol while using DURATAF 25MG TABLET may worsen the condition.
Drug-Disease Interactions: DURATAF 25MG TABLET should not be used in patients with bone disease or severe liver or kidney diseases.
If you take DURATAF 25MG TABLET , your doctor may regularly monitor liver function, kidney function, and bone density.
Hepatitis B: Hepatitis B is a potentially fatal liver infection caused by the hepatitis B virus (HBV). It is highly contagious (spreads from one person to another) and spreads by intimate contact with an infected individual, direct contact with infected blood, use of a contaminated needle, use of an infected razor/other personal objects, or transmission from mother to baby during birth. The virus can survive outside the body for up to 7 days. Chronic hepatitis B develops slowly, and symptoms may not be obvious until complications arise. Hepatitis B symptoms might occur three months after being exposed to the infection and can continue for two to twelve weeks. Chronic hepatitis B consequences include liver failure, liver cancer, and liver cirrhosis (scarring). Hepatitis B can be prevented by taking the vaccination.
Alcohol
Unsafe
Avoid drinking alcohol. Consuming alcohol while using DURATAF 25MG TABLET may worsen the condition.
Pregnancy
Caution
DURATAF 25MG TABLET is not recommended during pregnancy. However, your doctor may prescribe it for you during pregnancy if he/she feels that the benefit to you outweighs the risk. You should not take DURATAF 25MG TABLET without the doctor's advice.
Breast Feeding
Caution
Consult your doctor, and there is no substantial research yet on the use of DURATAF 25MG TABLET in breastfeeding/nursing mothers.
Driving
Caution
DURATAF 25MG TABLET can cause dizziness. If you feel dizzy when taking DURATAF 25MG TABLET , do not drive and use any tools or machines.
Liver
Caution
Consult your doctor before taking DURATAF 25MG TABLET if you have a liver impairment or any concerns regarding this. Your doctor will weigh the benefits and any potential risks before prescribing them to you.
Kidney
Caution
Consult your doctor before taking DURATAF 25MG TABLET if you have kidney impairment or any concerns regarding this. Your doctor will weigh the benefits and any potential risks before prescribing them to you.
Children
Unsafe
Should not use DURATAF 25MG TABLET in children below 12 years of age.
Country of origin
Manufacturer/Marketer address
We provide you with authentic, trustworthy and relevant information
Product Substitutes